SARS-CoV-2 Associated Respiratory Failure in a Preterm Infant and the Outcome after Remdesivir Treatment

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved..

Severe coronavirus disease 2019 (COVID-19) occurs in approximately 10% of neonates infected with severe acute respiratory syndrome coronavirus 2. Guidelines for optimal management of severe COVID-19 in neonates do not exist. In this report, we describe a late-preterm neonate with severe COVID-19, requiring invasive mechanical ventilation who recovered following treatment with remdesivir and high dose dexamethasone.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:41

Enthalten in:

The Pediatric infectious disease journal - 41(2022), 5 vom: 01. Mai, Seite e233-e234

Sprache:

Englisch

Beteiligte Personen:

Sarhan, Mohammed A [VerfasserIn]
Casalino, Maria [VerfasserIn]
Paopongsawan, Pongsatorn [VerfasserIn]
Gryn, David [VerfasserIn]
Kulkarni, Tapas [VerfasserIn]
Bitnun, Ari [VerfasserIn]
Gauda, Estelle B [VerfasserIn]

Links:

Volltext

Themen:

3QKI37EEHE
415SHH325A
Adenosine Monophosphate
Alanine
Journal Article
OF5P57N2ZX
Remdesivir

Anmerkungen:

Date Completed 14.04.2022

Date Revised 12.09.2023

published: Print

Citation Status MEDLINE

doi:

10.1097/INF.0000000000003504

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM337453756